Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer
- R. C. Coombes*
- , P. D. Badman
- , J. P. Lozano-Kuehne
- , X. Liu
- , I. R. Macpherson
- , I. Zubairi
- , R. D. Baird
- , N. Rosenfeld
- , J. Garcia-Corbacho
- , N. Cresti
- , R. Plummer
- , A. Armstrong
- , R. Allerton
- , D. Landers
- , H. Nicholas
- , L. McLellan
- , A. Lim
- , F. Mouliere
- , O. E. Pardo
- , M. J. Seckl*
*Corresponding author for this work
- Imperial College London
- Beatson Oncology Centre
- Addenbrooke's Hospital
- Freeman Hospital
- The Christie NHS Foundation Trust
- Russells Hall Hospital
- AstraZeneca
- Cancer Research UK
Research output: Contribution to journal › Article › Academic › peer-review
42
Downloads
(Pure)